Read more at MarketWatch.
Johnson & Johnson’s stock falls as profit beats but sales fall slightly short of estimates
Date: |
Sort by
Filter
Date
Items per page
-
Caterpillar’s stock is falling toward its worst day since 2020 after earnings
Caterpillar Inc. shares were dropping premarket after the company came up a bit short on first-quarter revenue as sales volumes declined.MarketWatch - Business -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
The colonialist overtones of EU’s green trade crusade
Many middle-income countries show reserves of pragmatic tolerance that Europeans do not necessarily deserveFinancial Times - Business -
Is Britain suffering from a ‘sick note culture’?
Rishi Sunak has vowed to get people back to work but data indicates problems with the diagnosis — and proposed solutionFinancial Times - Business - United Kingdom -
Meta proves AI hype has its limits
Artificial intelligence is a multibillion-dollar project with no clear timeline for revenuesFinancial Times - Business - Meta -
Chevron beats earnings estimates but profit falls on lower refining margins and natural gas prices
Chevron produced 1.57 million barrels of oil and gas daily in the U.S. for the quarter, an increase of 35% during the same period last year.CNBC - Business -
Exxon Mobil’s stock falls after profit and production drop below forecasts
Shares of Exxon Mobil Corp. dropped more than 3% Friday after the oil and gas giant reported first-quarter profit and production that fell below forecasts, even as revenue beat expectations by a wide margin.MarketWatch - Business -
Sanofi Sales, Profit Beat Forecasts
Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.The Wall Street Journal - World -
Sanofi Sales, Profit Beat Forecasts
Sanofi backed its full-year earnings guidance after it reported first-quarter profit ahead of consensus, with sales growth driven by continued strength in anti-inflammatory drug Dupixent and its new drug launches.The Wall Street Journal - Business
More from MarketWatch
-
Peacock raising prices by $2 a month ahead of Summer Olympics
Peacock is raising prices again, a year after its last price hike and just in time for the Summer Olympics.MarketWatch - Business -
Paramount CEO Bob Bakish is stepping down, to be replaced by 3 executives
Media and entertainment giant Paramount Global on Monday said that Chief Executive Bob Bakish was stepping down and would be replaced by a three-person office intended to help “materially streamline operations.”MarketWatch - Business -
AMC’s stock registers biggest decline in a month after preliminary first-quarter results
Shares of AMC Entertainment Holdings Inc. ended Monday’s session down 11.1% as the stock registered its biggest decline since April 1, when it fell 15.6%.MarketWatch - Business -
AT&T’s stock is misunderstood. Here are five reasons Barclays says it can soar.
AT&T’s decisions in recent years look better than those made by rivals, according to Barclays.MarketWatch - Business -
Coursera, Chegg stocks fall after weaker guidance for both edtech companies
Shares of Coursera Inc. and Chegg Inc. fell in the after-hours session Monday after both education-tech companies guided for weaker current quarters, and Chegg also announced a CEO change.MarketWatch - Business